Series of Presentations Highlights Company’s Novel Intra-aortic Pump that Treats Patients with Heart Failure and Worsening Renal Function
HOUSTON, TX – NOVEMBER 2, 2021 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today the schedule of presentations to be featured at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference in Orlando, Florida from November 4th to November 6th. The presentations include a spotlight on the company’s first US case treating a patient with heart failure (HF) and worsening renal function (WRF), a condition known as cardiorenal syndrome (CRS).
The series of presentations highlights the Aortix percutaneous intra-aortic mechanical circulatory support device, which is a platform technology in development that will initially target treatment of CRS…